H5N1 research: biosafety, biosecurity and bioethics

An international symposium

Organised by the Royal Society in partnership with the Academy of Medical Sciences and the Foundation for Vaccine Research with support from the American Society for Microbiology, the Bill & Melinda Gates Foundation, Fondation Mérieux, the German National Academy of Sciences Leopoldina, Institut Pasteur, and the Society for General Microbiology.

Click the 'view' buttons below to view each presentation. To download for off-line viewing be sure to right click the 'download' button and select 'save as'. Files are .mp4 - if you have any problems, please update your media player. Click here for further details of the meeting, including speaker biographies.

Session 1: The continuing influenza threat
		Welcome: John Skehel, Simon Wain-Hobson
		Avian and human H5N1 epidemiology and epizoonosis: Robert Webster
		Webster Discussion
		Risk assessing animal influenza viruses for pandemic threat: Malik Peiris
		Peiris Discussion
		Determinants of the pathogenicity of influenza viruses: Hans-Dieter Klenk
		Klenk Discussion
		Transmission of an influenza virus possessing an H5 hemagglutinin via respiratory droplets in ferrets: Yoshihiro Kawaoka
		Kawaoka Discussion
		Aerosol transmission of influenza A/H5N1 virus in ferrets: Ron Fouchier
		Fouchier Discussion
Session 2: Biosafety and biosecurity
		NSABB policy, processes and recommendations on communicating H5N1 research: Paul Keim
		Keim Discussion
		The ASM perspective on DURC: Kenneth Berns
		Our common goal: protecting public health from avian flu: Thomas Inglesby
		Inglesby Discussion
Session 3: Public health and bioethics
		Scientific freedom: A two pipe problem with a dual remedy solution: John Harris
		Harris Discussion
		Normative stances for the management of dual use technologies: Ross Upshur
		Upshur Discussion
		Asilomar: reflections on an earlier episode in biosafety (videoconference): Paul Berg
Session 4: Going wider
		Response to H5N1 and H1N1, experience of the 2009 pandemic Gordon Duff
		Duff Discussion
		A publishing and editing perspective: Philip Campbell
		Campbell Discussion
		H5N1 decisions: some important lessons learned: Bruce Alberts
		Alberts Discussion
		H5N1 - a funder's perspective: John Savill
		Savill Discussion
		Vaccine options: industry perspective: Jeffrey Almond
		Almond Discussion
		H5N1, the public, public health and public trust: Laurie Garrett
		Garrett Discussion
		Doomsday virus or no big deal: view from the newsroom: David Brown
		Cybersecurity, scientific data and public trust: Bruce Schneier
		Schneier Discussion
Session 5: Observations and discussion
		Open floor discussion
		Observations: Peter Doherty
		Observations: Arthur Caplan
		Caplan Discussion
		Closing remarks: John Skehel and Simon Wain-Hobson

H5N1 research: biosafety, biosecurity and bioethics

An international symposium

Session 1: The continuing influenza threat

Session 2: Biosafety and biosecurity

Session 3: Public health and bioethics

Session 4: Going wider

Session 5: Observations and discussion

Actionstream Direct Media - Fast turnaround event webcasting